Insight

Jun 10, 2025, 17:40

ESTRO Shared Prospective Study on Immune Response to SBRT in Lung Metastases

ESTRO shared a post on X about a recent study published in Radiotherapy and Oncology:

“A prospective study of immune responses in patients with lung metastases treated with SBRT with or without concurrent systemic treatment, published in the Radiotherapy and Oncology journal.

Read it before your patients.“

Immune Response

Title: A prospective study of immune responses in patients with lung metastases treated with stereotactic body radiotherapy with or without concurrent systemic treatmet

Journal: Radiotherapy and Oncology

Authors: Eleni Gkika, Elke Firat, Sonja Adebahr, Erika Graf, Ilinca Pop, Alexandra Eichhorst, Gianluca Radicioni, Simon S. Lo, Simon K.B. Spohn, Ursula Nestle, Nils H. Nicolay, Gabriele Niedermann, Anca-L. Grosu, Dan G. Duda

Read the full article.

Immune Response

More posts featuring ESTRO on OncoDaily.

Alexandra Eichhorst Anca L. Grosu cancer Dan G. Duda Eleni Gkika Elke Firat Erika Graf ESTRO Gabriele Niedermann Gianluca Radicioni Ilinca Pop immune response immunotherapy Lung cancer Nils H. Nicolay OncoDaily Oncology Radiotherapy and Oncology SBRT Simon K.B. Spohn Simon S. Lo Sonja Adebahr Ursula Nestle

MiNK Therapeutics Stock Surges on Breakthrough Testicular Cancer Remission and iNKT Cell Therapy Progress

Tabelecleucel (Ebvallo) FDA Update: Approval Delayed Despite Positive Phase 3 Data

New Paper Alert: Breakthrough iNKT Cell Therapy Achieves Complete Remission in Metastatic Germ Cell Tumor

"God Invented This" - Pat Soon-Shiong on Cancer Discovery

Kevin Conroy: Oncodetect is Now Covered by Medicare in Stage IV Colorectal Cancer